LifeLens Technologies Expands Executive Leadership Team and Board

LifeLens Technologies Inc. (LifeLens) has reconfigured its executive management team, with Daniel J. Sullivan assuming the top spot (chairman/CEO), Brent A. Moen carrying out chief financial officer (CFO) duties, and Richard J. Buchholz taking a seat on the company’s Board of Directors.
 
“With LifeLens, we have a significant opportunity to disrupt healthcare and make a meaningful impact on patients and healthcare professionals, and we are thrilled to have Brent and Rick join the LifeLens team,” Sullivan said. “Brent and Rick collectively bring over 60 years of combined experience and track records that have led to business growth while transforming clinical care, and now their skills will help enable LifeLens to realize its potential.”  
 
Sullivan brings to his position more than 40 years of leadership in the medical device industry, where he has been a principal, CEO, board member, or co-founder of 11 startup companies, 10 of which have been acquired. These companies include SciMed Life Systems Inc., which was acquired by Boston Scientific Corporation in 1995, The WATCHMAN (Atritech Inc.), which was acquired by Boston Scientific Corporation in 2011, superDimension Ltd., which was acquired by Covidien plc in 2012 and NeuWave Medical Inc., which was acquired by Johnson & Johnson in 2016.
 
Moen has more than 30 years of experience in finance. He most recently served as CFO of Tactile Systems Technology Inc. from September 2018 until March 2023. Prior to joining Tactile Systems Technology, Moen was CFO of Entellus Medical Inc. from 2016 until its acquisition by Stryker Corporation in 2018. Moen also served as CFO of ABRA Auto Body & Glass LP, and Regis Corporation.
 
Since 2014, Buchholz has served as CFO of Inspire Medical Systems Inc., a developer and commercializer of minimally invasive solutions for obstructive sleep apnea. Prior to joining Inspire, Buchholz was CFO at superDimension Ltd. from 2006 to 2013. Buchholz also served as CFO of Vascular Solutions Inc., which was acquired by Teleflex Incorporated in 2017.
 
LifeLens, a private healthcare company, has developed a system incorporating artificial intelligence capable of monitoring physiological data to assess real-time health readiness and performance. The LifeLens system can provide monitoring both remotely and in the hospital or doctors’ office, and can wirelessly transmit real‐time scenarios providing actionable information that will allow health professionals to make data-driven decisions to improve patients’ health. The LifeLens product is cleared by the U.S Food and Drug Administration (FDA) for remote single channel electrocardiogram (ECG) and heart rate monitoring. The system is not yet FDA-cleared for other indications.
 
Since 2019, LifeLens has been testing its wearable physiological sensors with the United States Armed Forces, allowing military leaders the ability to monitor their troops health, readiness, and performance in real-time training and operational environments.